Summary
MetLife, Inc. announced on August 8, 2012, its successful issuance of $750 million in aggregate principal amount of 4.125% Senior Notes due 2042. This offering was conducted under MetLife's existing shelf registration statement and a related prospectus supplement, indicating efficient capital management and access to public debt markets. The issuance of these senior notes provides MetLife with additional long-term funding, which can be utilized for various corporate purposes, including general corporate uses, debt refinancing, or strategic initiatives. The fixed 4.125% interest rate on these notes, maturing in 2042, suggests a favorable borrowing cost for the company at the time of issuance, reflecting investor confidence in MetLife's financial stability.
Key Highlights
- 1MetLife issued $750 million in Senior Notes due 2042.
- 2The notes carry a fixed interest rate of 4.125%.
- 3The offering was made under an existing shelf registration statement (Form S-3) and a prospectus supplement.
- 4The issuance occurred on August 8, 2012, as detailed in an 8-K filing dated August 9, 2012.
- 5Underwriting and pricing agreements were executed with Barclays Capital Inc., Citigroup Global Markets Inc., and UBS Securities LLC as representatives of the underwriters.
- 6The notes are senior unsecured obligations of MetLife.